As three of four FOS genes have emerged as recurrently mutated in human tumours, and given the structural and functional similarities between members of this gene family, we suspect that there may well be neoplasms harbouring yet undiscovered alterations in FOSL2, which clinical sequencing programmes of rare tumours can help reveal. This evidence concerns the gene FOS and neoplasm.